PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2024-10-30 ms1000000741572856 来自广东省

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：医学;神经生物学
经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。

28 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2024-02-26 123bc054m90暂无昵称来自山东省

文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗

138 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2021-07-20 ms5000000115506285

总体来说效率挺高
Stage Start Date
Under Review 2021-07-19
Under Editor Review 2021-07-18
Under Editorial Board Review 2021-07-14
Quality Control Review Completed 2021-07-14
Quality Control Issue Identified 2021-07-13
Quality Control Review Started 2021-07-11
Author Approved Submission 2021-07-11
Preliminary Manuscript Information Submitted 2021-07-11

357 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2024-02-15 ms6000001790334235 来自重庆

学到了很多

144 0

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2021-07-22 147c8eeam09(暂无昵称)

under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？

458 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2023-07-05 ms4000001367023473 来自山东省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：发育
经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗

188 0

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2022-11-14 ms3000000956234154

请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？

279 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2022-05-17 slientwo

PNAS和EMBO J哪一个更好呢，更能当作代表作呢。

361 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2022-06-15 osmataku

听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐

351 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234062, encodeId=b486223406238, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：医学;神经生物学 经验分享：非必要不要投这个杂志，基本是给美国院士的指标，目前已经2万多篇稿件了，发表才2千篇，中的概率本来就低，然后编辑这一块处理超级超级慢，需要通过两关编辑同意才会送审，第一关编辑就需要20天才会处理。认清这个杂志了，2021年的投稿经验完全不适用这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Wed Oct 30 09:39:25 CST 2024, time=2024-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了，怎么办，是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高 Stage Start Date Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了，大家知道是什么情况吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：发育 经验分享：一审更新了两次 under review 状态，有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation，这预示是拒稿还是可以修回啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢，更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表，有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：医学;血液病 经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=586, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=)]

2021-02-24 ms279145567006567

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：医学;血液病
经验分享：我这篇文章先投了NC，直接被编辑拒稿。在心灰意冷的情况下，投到了PNAS上，结果不到一个星期编辑就返修了，就提了一些格式、标点、用词上的一些问题，然后很快就改好返稿。早上提交，晚上8点就进入review阶段……这中间又返修了一次，需要补数据……虽然过程很复杂，又遇难疫情不能回校补实验。延期返稿时间两次（合计两个月），好在返回去之后就没有经过太多修改，很快就接收了。第一篇以一作的身份发表在这种顶级刊物上，心情很激动。

586 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务